AstraZeneca

AstraZeneca commits $15 billion investment in China through 2030 to expand R&D and manufacturing

Pinktober 2025 – Raising awareness in the global fight against breast cancer

AstraZeneca dethroned as UK’s most valuable company following U.S. drug price shake-up

Department of Health – Abu Dhabi partners with Abu Dhabi Health Data Services and AstraZeneca to launch innovative breast cancer research platform